baber/WOPTO huggingface dataset:
Patent JP-2753300-B2 (JP)
IPC: C07C327/20
Filed: 1989-01-19
Granted: 1998-05-18
Abstract: Aromatic esters and thioesters have the formula   <IMAGE> (I) wherein X represents oxygen or sulfur, R1 represents -CH2OH, -CH(OH)-CH3, -COOR5 or  <IMAGE>  R5 represents hydrogen, lower alkyl, lower alkenyl, monohydroxyalkyl or polyhydroxyalkyl, r' and r'' represent hydrogen, lower alkyl, monohydroxyalkyl, polyhydroxyalkyl, aryl or benzyl optionally substituted, the residue of an amino acid or aminated sugar, or taken together form a heterocycle, R2represents alpha , alpha '-disubstituted alkyl having 4-12 carbon atoms or mono- or polycyclic cycloalkyl having 5-12 carbon atoms whose carbon linking carbon is trisubstituted, R3represents hydrogen, lower alkyl, or -Si(CH3)2R'3 wherein R'3 represents lower alkyl, and R4 represents hydrogen or lower alkyl, and the salts of these aromatic esters and thioesters of formula (I) when R5 represents hydrogen. These aromatic esters and thioesters can be used in human and veterinary medicine and in cosmetic formulations.
Patent AU-707090-B2 (AU)
Title: Immersible rotary disc filtration device
Inventor: ROLCHIGO PHILIP M
IPC: B01D33/17
Filed: 1996-11-22
Granted: 1999-07-01
Abstract: Rotary disc filtration devices and filtration processes using those devices are disclosed. The devices have one or more fluid filtration gaps into which fluid to be filtered into permeate and retentate is placed. Each fluid filtration gap is defined by a disc and a filter, one of which rotates with respect to the other. The filter is carried on a filter member. The discs and interleaved filter members may be suspended from the top of the device, the top may rest on a vessel containing the fluid to be filtered, the discs may be attached to a single shaft for rotation, and the filter members may be suspended from a sleeve around the shaft, which sleeve keeps the filters centered with respect to the discs. Removal of the device's top removes the discs and filter members together, facilitating maintenance. Each filter member may have a peripheral lip and the lips of adjacent filter members may be sufficiently close to one another to substantially restrict the flow of retentate out of the fluid filtration gap. Retentate flowing out of each fluid filtration gap may be directed into the vessel to counteract the tendency of the fluid in the vessel to rotate in the same direction as the discs are rotated, or the retentate may be recycled directly to the fluid filtration gaps. The liquid level in the vessel may be held constant using a dual-pipe system and three-head peristaltic pump.
Patent AU-620025-B2 (AU)
Title: Method of preventing pneumocystis carinii pneumonia using pentamidine in an aerosol form
Inventor: BERNARD EDWARD M
IPC: A61K31/155
Filed: 1988-03-21
Granted: 1992-02-13
Abstract: There is described a composition for the prophylaxis or treatment of Pneumocystis carinii pneumonia which comprises an aerosol spray of pentamidine or a pharmaceutically acceptable salt thereof wherein the aerosol spray contains significant amounts of particles having an aerodynamic diameter in the range 0.5 to 8.0 microns.
Patent AU-779871-B2 (AU)
Title: Human monoclonal antibodies against TGF-beta II receptor and medicinal use thereof
Inventor: SAKAMOTO SHINJI
IPC: A61P17/02
Filed: 2000-11-17
Granted: 2005-02-17
Abstract: Various human monoclonal antibodies that bind to human TGF- beta type II receptor to inhibit the signal transduction of human TGF- beta  signal into cells are produced by immunizing human antibody-producing transgenic mice generated by genetic engineering techniques with the soluble human TGF- beta  type II receptor. Further, these human monoclonal antibodies were demonstrated to be effective for preventing and treating various diseases induced by human TGF- beta  in various organs (for example, tissue fibrosis).
Patent AU-555758-B2 (AU)
Title: Preparation of aseptic juice beverages
Inventor: RAUSING HANS
IPC: C13B10/00
Filed: 1983-05-20
Granted: 1986-10-09
Abstract: The invention relates to a method for the preparation of an aseptic juice beverage, the aroma substances either being neutralized or being extracted from the fruit juice treated before, or in connection with, the sterilization through heating of the juice, whereupon the aroma substances recovered, or obtained in some other manner, are sterilized separately without heating, and that the separately sterilized aroma substances are mixed with the heat-sterilized fruit juice, whereupon the mixture is packed under aseptic conditions in internally sterilized, bacteria-tight packages.
Patent AU-683346-B2 (AU)
Title: High speed laying head
Inventor: SHORE TERENCE M
IPC: B21C47/14
Filed: 1995-03-28
Granted: 1997-11-06
Abstract: A rolling mill laying head has a quill (14) supported for rotation about its longitudinal axis (X) between axially spaced first and second bearing assemblies (16,18). A laying pipe (24) is carried by the quill for rotation therewith. The laying pipe has an entry section (24a) lying on the quill axis between the first and second bearing assemblies, and a curved intermediate section (24b) extending through and beyond the second bearing assembly to terminate at a delivery end (24c) spaced radially from the quill axis to define a circular path of travel. The dimension (A) by which the laying pipe extends beyond the second bearing assembly is less than the diameter (D) of the circular path.
Patent AU-690647-B2 (AU)
Title: Mobile communication system and call control method
Inventor: FRIMAN LEIF
IPC: H04W88/18
Filed: 1995-03-03
Granted: 1998-04-30
Abstract: PCT No. PCT/FI95/00122 Sec. 371 Date Sep. 9, 1996 Sec. 102(e) Date Sep. 9, 1996 PCT Filed Mar. 3, 1995 PCT Pub. No. WO95/24789 PCT Pub. Date Sep. 14, 1995A mobile communication system and a call control method for the mobile communication system allowing calls to be established between mobile stations located in an area of a same base station system. Uplink transmission frames are transmitted from a first base station communicating with one of a calling and a called mobile station to a second base station communicating with another of the calling and the called mobile station via the same base station system. The mobile communication system and the call control method for the mobile communication system also allow calls to be established between mobile stations in an area of two base station systems having a direct network link therebetween. The uplink transmission frames are transmitted from the first base station communicating with one of the calling and the called mobile station to the second base station communicating with another of the calling and the called mobile station via the two base station systems having the direct network link therebetween.
Patent AU-606733-B2 (AU)
Title: A method for producing propellant charges and charges produced according to this method
Inventor: JOHANSSON LENNART
IPC: F42B5/16
Filed: 1988-08-19
Granted: 1991-02-14
Abstract: The disclosure relates to a method of producing charges for cannons with extremely high charge density and favourable burning properties from the standpoints of both wear and pressure vs time characteristics. According to the invention, the charge is formed of mutually parallel, bundled tubular propellant rods (1) which have been provided with specially designed rupture points (3) which cause the charge to be ignited as a pure tubular propellant charge of large length in relation to the diameter of the combustion channels, but finally burns as a pure granular propellant. The disclosure also relates to propellant charges produced according to the disclosed method.
Patent AU-773320-B2 (AU)
Title: Golf game
Inventor: JOLLIFFE STEVEN PAUL
IPC: A63B57/00
Filed: 2001-01-04
Granted: 2004-05-20
Abstract: A golf game employing r.f-tag coded golf balls has a playing area with r.f. antennae located underneath to enable the number of strokes taken by a player to be counted. Separate antennae are provided for the tee area and hole, respectively, and the antennae around the hole are smaller to improve resolution. The antennae are connected to a computer which monitors successive moving and stationary phases of a golf ball to count the number of strokes taken by a player.
Patent AU-718590-B2 (AU)
Title: A package assembly for keeping, storing, displaying and handling disc-shaped products
Inventor: LINDBLOM GORAN
IPC: G11B33/04
Filed: 1997-03-21
Granted: 2000-04-20
Abstract: PCT No. PCT/SE97/00489 Sec. 371 Date Mar. 15, 1999 Sec. 102(e) Date Mar. 15, 1999 PCT Filed Mar. 21, 1997 PCT Pub. No. WO97/38919 PCT Pub. Date Oct. 23, 1997A package assembly for keeping, storing, displaying and handling disc-shaped products, such as compact discs and the like, wherein the assembly is comprised of a sleeve or pocket that is produced by folding and/or gluing a first paperboard or cardboard-like blank, and a slide or tray which is intended to removably receive at least one disc-shaped product and which is produced by folding and/or gluing a second paperboard or cardboard-like blank, wherein the sleeve has an opening through which the product-carrying slide can be inserted and withdrawn, wherein the slide includes product-constraining means, and wherein the sleeve and the slide include mutually coacting means which function to maximize the extent to which the slide can be withdrawn from the sleeve for the removal and insertion of a product into the space intended therefor. According to the invention, a folded part of the slide in the region of its bottom part functions both as a part of a product-receiving pocket and as a partition wall that enables two products to be received in mutually parallel and mutually separated relationship, wherein the folded part includes a separate foldable flap that forms a bottom abutment for products received on respective sides of the partition wall, wherein the bottom abutment of said flap also functions to restrict the extend to which the slide can be withdrawn from the sleeve.
Patent AU-781577-B2 (AU)
Title: Therapeutic phosphodiesterase inhibitors
Inventor: DALE RODERIC M K
IPC: A61P1/04
Filed: 1999-12-15
Granted: 2005-06-02
Abstract: This patent describes the invention of a series of novel therapeutic oligonucleotides targeted at inhibiting expression of genes coding for Phosphodiesterase 4. They are useful as analytical tools in the study of individual PDE isoforms and in the therapeutic treatment of depression, thrombosis, cystic fibrosis, gastric lesions, pulmonary hypertension, glaucoma, multiple sclerosis, atopic dermatitis, asthma and other allergic disorders as well as other illnesses in which an increase of cyclic AMP or a decrease in phosphodiesterase levels is useful.
Patent AU-653859-B2 (AU)
Title: Slag granulation
Inventor: FEATHERSTONE WILLIAM BARRY
IPC: B22F9/08
Filed: 1992-09-08
Granted: 1994-10-13
Abstract: PCT No. PCT/GB92/01635 Sec. 371 Date Mar. 2, 1994 Sec. 102(e) Date Mar. 2, 1994 PCT Filed Sep. 8, 1992 PCT Pub. No. WO93/06250 PCT Pub. Date Apr. 1, 1993.A granulator comprises a rotary atomiser (1) on to which the molten material to be granulated is poured in a stream. The rotation of the atomiser (1) causes the molten material to be ejected therefrom in the form of globules. No fluid jets are used to break up the molten material. The globules pass through an enclosure (6) and partially freeze to form granules which are collected in an annular trough (10). A gas is injected into the trough (10) to induce a circumferential movement of the granules within the trough towards at least one exit from the trough (10).
Patent AU-731049-B2 (AU)
Title: Highly efficient controlled expression of exogenous genes in e. coli
Inventor: BROWN WILLIAM C
IPC: C07K14/535
Filed: 1999-01-27
Granted: 2001-03-22
Abstract: The invention relates generally to recombinant methods and materials for effecting the microbial production of useful polypeptides. More particularly, the invention relates to expression vector systems which utilize a translational repressor system, and transcriptional control proteins to provide a highly efficient, tightly regulated, staged inducible promoter system capable of expressing exogenous genes, including toxic genes, in E. coli.
Patent AU-625897-B2 (AU)
Title: Membrane filtration apparatus and method of making a membrane filtration unit
Inventor: MOLLER JENS KLOPPENBORG
IPC: B01D/
Filed: 1988-12-06
Granted: 1992-07-16
Abstract: Liq. is sepd. into permeate and concentrate fractions by multiple membranes mounted in cassettes. The cassettes are assembled as a stack together with manifolds which supply the feed and remove the prods. Flow regulating plates are sandwiched between adjacent cassettes and give a personality to the stack. For example the plates may configure the stack so that all the cassettes are in parallel, are in series or a series/parallel configuration.
Patent AU-754305-B2 (AU)
Title: Communications network
Inventor: POUSTIE ALISTAIR JAMES
IPC: H04B10/299
Filed: 2000-03-27
Granted: 2002-11-14
Abstract: A device and method for correcting for timing jitter of an optical data pulse in an optical transmission system. During transmission, a data pulse may suffer jitter. Its arrival time at a node may be temporally offset from its predicted arrival time. Data pulses are timed so that they may be received at a detector disposed downstream of the node at a predetermined time. The device includes a source of chirped optical pulses and a node, which has a first input arranged to receive a chirped optical pulse. The node has a second input arranged to receive a data pulse. The node includes an optical gate arranged to generate an output pulse in response to the first pulse and the data pulse received at the first and second inputs, respectively, having a wavelength dependent upon the time at which the data pulse is received at the second input. The device further includes an optically dispersive medium after passage through which, the output pulses are correctly retimed in order to correct for the timing jitter.
Patent AU-771373-B2 (AU)
Title: Lipoglycan compositions and methods of treating parasitic infections
Inventor: SEMPREVIVO LLOYD H
IPC: A61P33/00
Filed: 2000-03-10
Granted: 2004-03-18
Abstract: A composition for and a method of eliciting in a vertebrate a protective immune response against an eukaryotic parasite are disclosed. The method includes administering to the vertebrate a composition having a carrier group coupled to an oligosaccharide obtained from a lipoglycan found on the surface of an eukaryote. The composition is administered in an amount sufficient to elicit a protective immune response against the parasite.
Patent AU-696423-B2 (AU)
Title: Heterocycle substituted propenoic acid derivatives as NMDA antagonists
Inventor: HARRISON BOYD L
IPC: C07D401/06
Filed: 1995-09-21
Granted: 1998-09-10
Abstract: The present invention is new 3-(heterocyclic)-propenoic acid derivatives and pharmaceutical compositions thereof. These new 3-(heterocyclic)-propenoic acid derivatives are useful as NMDA antagonist.
Patent AU-667886-B2 (AU)
Title: Method for preparing beta-phenylisoserine and analogues thereof
Inventor: BOURZAT JEAN-DOMINIQUE
IPC: C07C229/34
Filed: 1993-03-08
Granted: 1996-04-18
Abstract: PCT No. PCT/FR93/00224 Sec. 371 Date Sep. 26, 1994 Sec. 102(e) Date Sep. 26, 1994 PCT Filed Mar. 8, 1993 PCT Pub. No. WO93/17997 PCT Pub. Date Sep. 16, 1993This invention relates to a method for preparing  beta -phenylisoserine and analogues thereof having general formula (I)    <IMAGE>  (I)  from an aromatic aldehyde and an  alpha -methylarylamine-S, and through a lactam of general formula (II) as described herein. The acids of general formula (I) (R=H) may be used to prepare taxane derivatives having remarkable antitumoral and antileukaemic activity.
Patent AU-693279-B2 (AU)
Title: Analyte-controlled liquid delivery device and analyte monitor
Inventor: GROSS JOSEPH
IPC: A61M1/36
Filed: 1995-10-27
Granted: 1998-06-25
Abstract: A liquid delivery device comprising a housing having a lower surface for application to the skin of a subject and having a reservoir and a gas generation chamber therein separated by a displaceable membrane. Gas generated by an electrolytic cell under the control of a microprocessor causes the gas generation chamber to expand and the reservoir to contract, thereby discharging a liquid drug, such as insulin, from the reservoir via a hollow delivery needle extending from the lower surface. The delivery needle and a sensor needle both extend from the lower surface a sufficient distance so as to penetrate through the epidermis and into the dermis when the housing is pressed against the skin. The sensor needle has an enzymatic coating for the detection of an analyte, such as glucose in the subject's plasma. The delivery needle is made of platinum-iridium, and a current passes between the needles and a potentiostat circuit according to the amount of glucose detected. A reference electrode (silver/silver chloride) which rests against the subject's skin increases the accuracy of the glucose measurement. The current through the potentiostat circuit is measured by a voltmeter and a signal from the voltmeter is amplified and communicated to the microprocessor which determines the correct rate of delivery of the drug on the basis of the level of analyte detected in the subject's plasma.
Patent AU-584901-B2 (AU)
Title: Modular apparatus for cell culture
Inventor: BISCONTE JEAN-CLAUDE
IPC: C12M1/00
Filed: 1985-05-29
Granted: 1989-06-08
Abstract: The present invention relates to a modular apparatus for cell culture, comprising in the same sealed enclosure (2) with isotherm walls (3): at least one device (1, R, E) for storing culture containers, at least one temperature regulation device (7), a closed circuit filtered laminar flow sterilization device (11, 12, 13, 14), a device for supplying and regulating gas, such as air, CO2, vapor and/or similar, and in that the enclosure possibly contains at least one additional device for carrying out any one of the conventional cell culture operations, or any other specific operation, and defining a modular work post chosen depending on the needs. The apparatus may also comprise an automatic and programmable handling arm (B) and a microprocessor for controlling and processing the data.
Patent AU-653106-B2 (AU)
Title: Integrated personal/cellular communications system architecture
Inventor: LABORDE ENRIQUE
IPC: H04W16/32
Filed: 1993-08-13
Granted: 1994-09-15
Abstract: An integrated PCN/DNC system architecture has a switching center (22), coupled to a public switched telephone (PSTN), which selectively transfers signals between the PSTN and a digital cellular network (DCN) or a personal communications network (PCN) which is allocated a portion of the cellular communications band by a local cellular operator. Each PCN subnetwork (20) of the PCN includes several microcells (18) arranged in a multi-dimensional grid, and the allocated cellular channels are divided into sets assigned to columns of the grid. The allocated portion of the cellular spectrum is reused within each PCN subnetwork (20) by assigning the same set to more than one of the columns so that different communications signals can be transferred over the same cellular channels. <IMAGE>
Patent AU-712680-B2 (AU)
Title: Three component chimeric antisense oligonucleotides
Inventor: WOOLF TOD M
IPC: C12N15/09
Filed: 1997-09-26
Granted: 1999-11-11
Abstract: This invention relates to antisense oligonucleotides that target mRNAs in cells as substrates for the cellular enzyme RNase H and thereby cause specific degradation of the targeted mRNA. The oligonucleotides have three components: a RNase H activating region, a complementarity region and 3' and 5' ends. The invention optimizes each of the components to resist intracellular nucleases, to increase hybridization to target mRNA, to specifically inactivate target mRNA in cells, and to decrease cytotoxicity.
Patent AU-731016-B2 (AU)
Title: A coated sodium phosphate bowel cleanser
Inventor: WOOD THOMAS G
IPC: A61K9/16
Filed: 1997-11-13
Granted: 2001-03-22
Abstract: There is described a sodium phosphate bowel cleansing composition which has improved taste over conventional sodium phosphate compositions. The composition comprises free flowing monobasic sodium phosphate and dibasic sodium phosphate powders or crystals which have been coated with at least one edible grade film forming polymer such as hydroxypropylmethyl cellulose or polyethylene glycol.
Patent AU-769544-B2 (AU)
Title: Electric/acoustic transducer module, intra-aural hearing-aid and method for producing an intra-aural hearing aid
Inventor: VONLANTHEN ANDI
IPC: H04R25/00
Filed: 2000-06-06
Granted: 2004-01-29
Abstract: The invention relates to an electric/acoustic transducer module for a hearing-aid worn behind the ear or intra-aurally. Said transducer module has a loudspeaker, comprising a diaphragm (5), operated by an electromotive drive. The diaphragm (5) is situated in a loudspeaker housing (8) which is mounted in a capsule housing (13) in a spring-loaded manner. An intermediate gap (11) extends between the capsule housing (13) and the loudspeaker housing (8). A first chamber (R1) on one side of the diaphragm (5) in the loudspeaker housing (8) is linked to the acoustic outlet (AA) of the transducer assembly, whilst a second chamber (R2) on the other side of the diaphragm (5) in the loudspeaker housing (8) is linked (9) to the intermediate gap (11).
Patent AU-709220-B2 (AU)
Title: Hydromassage bathtub with wide-beam ultrasound emission devices
Inventor: GUZZINI VIRGILIO
IPC: A61H23/00
Filed: 1996-04-10
Granted: 1999-08-26
Abstract: A hydromassage bathtub with ultrasound micromassage system comprising a plurality of ultrasound emission devices (13, 113) distributed over the walls of the bathtub. The ultrasound emission devices (13, 113) comprise means (23, 26; 118, 125) for orientating the direction of emission of the ultrasounds into a wide beam, at least 10 cm. wide at a distance of 20 cm. from the source. In case of conical beam, the means orient the beam into a solid angle of not less than 30 DEG  and advantageously at least 50 DEG . With one ultrasonic emitting element (24) inside the emission device the emission beam obtained is superior to the natural width or divergence of said element. <IMAGE>
Patent AU-580137-B2 (AU)
Title: Improvements in or relating to protective equipment for horses
Inventor: WESTROPP HILARY ANN
IPC: A61D9/00
Filed: 1986-02-17
Granted: 1989-01-05
Abstract: The invention relates to an over-reach boot for horses, ponies and the like to protect the animal's forelegs from kicks by its rear legs. The boot comprises a number of strips or panels (4) which preferably overlap and which are provided at their upper portions (13) with loops (14) and apertures (16) by which a desired number of panels (4) are threaded onto a strap (6) which is fastened around the foreleg with a non-slip buckle (8).
Patent AU-705239-B2 (AU)
Title: Avoidance of precipitation in 3-isothiazolone formulations
Inventor: CLARKE PHILIPPA
IPC: A01N43/80
Filed: 1996-05-27
Granted: 1999-05-20
Abstract: The formation of unsightly precipitation in isothiazolone formulations during storage is avoided by the addition of ppm levels of a Cu<2+> salt.
Patent AU-777193-B2 (AU)
Title: Production method of citalopram, intermediate therefor and production method of the intermediate
Inventor: IKEMOTO TETSUYA
IPC: C07C65/00
Filed: 2000-09-07
Granted: 2004-10-07
Abstract: Citalopram can be industrially and economically produced and at a high yield by reacting a compound of the following formula ÄVIÜ with 3-(dimethylamino)propyl chloride in the presence of at least one of N,N,N',N'-tetramethylethylenediamine and 1,3-dimethyl-2-imidazolidinone and a condensing agent. The compound of the following formula ÄIIIÜ, which is a key compound for the production of citalopram, can be easily produced by subjecting the compound of the following formula ÄIIÜ to reduction and cyclization. <CHEM>